Skip to main content

Advertisement

Table 3 Utilisation of antimalarial drugs across demographic categories

From: Adherence to treatment guidelines for uncomplicated malaria at two public health facilities in Nigeria; Implications for the ‘test and treat’ policy of malaria case management

  Gender Age category (years)
Antimalarial drugs Female n (%) Male n (%) Under 5 n (%) 5 – 12 n (%) 13 – 18 n (%) 19 and above n (%)
Artemisinin-based combination therapy (ACT) 1127 (93) 881(94) 182(85) 45 (87) 101(97) 1286 (95)
  Artemether-lumefantrin (AL) 568 (50) 446 (51) 128 (70) 31 (69) 50 (50) 624 (49)
  Artesunate-amodiaquine (ASAQ) 113 (10) 125 (14) 29 (16) 3 (7) 15 (15) 184 (14)
  Artesunate-mefloquine (ASMF) 168 (15) 64 (7) - - 5 (5) 113 (9)
  Artesunate-sulphadoxine + pyrimethamine (ASSP) 115 (10) 72 (8) 18 (10) 11 (24) 9 (9) 82 (6)
  Dihydroartemisinin-piperaquine (DHAPQ) 163 (14) 174 (20) 7 (4) - 22 (22) 283 (22)
Monotherapy 80(7) 61(6) 32(15) 7 (13) 3 (3) 70 (5)
  Sulphadoxine + pyrimethamine (SP) 39 (49) 28 (44) 4 (13) 2 (29) 2 (67) 44 (63)
  Artesunate (AS) 23 (29) 17 (27) 11 (34) 1 (14) 1 (33) 19 (27)
  Amodiaquine (AQ) 7 (9) 6 (9) 12 (38) 1 (14) - -
  Quinine (QN) 2 (3) 4 (6) - 1(14) - 5 (7)
  Proguanil (PG) 9(11) 6(14) 5 (16) 2 (29) - 2 (3)
Co-medication       
  Analgesics 920 (76) 783 (83) 119 (59) 34 (54) 87 (84) 1148 (85)
  Vitamin preparations 701 (56) 646 (69) 106 (52) 35 (56) 69 (66) 951 (70)
  Antibiotics 569 (47) 502 (53) 115 (57) 23 (37) 59 (57) 720 (53)
  1. NAUMC = Nnamdi Azikiwe University Medical Center, NAUTH = Nnamdi Azikiwe University Teaching Hospital.